Abstract
A patient who received smallpox vaccinations to treat a recurrent genital herpes simplex virus infection had development of recurrent herpes at the vaccination site while his genital lesions continued unabated. Until smallpox vaccine is removed from the general market or reclassified as a restricted biological, the inappropriate use of this agent will continue. (JAMA1982;247:2704-2705)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
